Turning around Baxter: A huge challenge for the new CEO
When he takes the reins in January at Baxter International, Jose Almeida will face huge challenges that will test his skills and patience. He needs to recharge a sprawling operation...
Home > Reviews
All Stories
As AbbVie’s profits climb, company says Humira will remain potent
Even as competitors rush to develop low-cost versions of Humira, AbbVie's powerhouse drug, the North Chicago company is doubling down on efforts to keep the medicine ringing up sales and...
Baxalta rings up strong performance after spinoff
Baxalta, the bioscience company spun off from Baxter International this summer, reported strong third-quarter sales and profits on robust demand for its hematology and immunology products. The company, based in...
Illinois companies paid $1.87 billion in fines over 5 years: report
This is a list no company would want to be on. Scores of Illinois-based companies are included in a new report that tallied fines paid for health, safety and environmental...
Baxter names new CEO
Baxter International, the Deerfield-based maker of hospital and renal products, has named Jose Almeida chairman and chief executive, effective Jan. 1. Almeida, 53, was chairman and chief executive of Covidien,...
Baxter cutting 1,400 jobs, possibly 240 in Illinois
Baxter International, the Deerfield-based maker of hospital and renal products, saw third-quarter profits drop sharply — largely due to the costs of spinning off its pharmaceutical operations — and said...
Abbott Labs: Paying dividends for 367 consecutive quarters since 1924
The 127-year-old warhorse, Abbott Laboratories, still races along in one key area: paying dividends. The North Chicago health care giant has been paying dividends, through good times and bad, for...
AbbVie defends hepatitis C drugs, stock bounces back
AbbVie defended its two medicines for treating hepatitis C as safe and effective for the vast majority of patients, and said risks of serious liver injury are limited to only...
AbbVie shares plunge after FDA warning
Shares in Chicago pharmaceutical giant AbbVie Inc. fell as much as 15 percent Thursday afternoon after the Food and Drug Administration warned that the company's treatments for hepatitis C could...
Strong sales overseas help Abbott push quarterly profits up 7.6 percent
Abbott Laboratories, maker of heart stents and diagnostic equipment, said Wednesday that strong sales of generic drugs in emerging markets overseas led the way to a robust third-quarter performance, and...